Considering that COVID-19 infection was associated with the occurrence of hyperglycemia and new-onset diabetes [43], it is believed that the virus directly affects β-pancreatic cells due to increased inflammation with secondary reduction in insulin secretion, but also with insulin resistance probably due to higher levels of counterregulatory hormones and cytokines [44,45], highlighted in the present study by increasing the TyG and TyG-BMI index. The gene discussed is INS; the disease is Hyperglycemia.